Related Experiment Video
Updated: May 27, 2026

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
Published on: May 30, 2017
New-generation vaccines against cholera.
John Clemens1, Sunheang Shin, Dipika Sur
1International Vaccine Institute, Seoul National University Research Park, San 4-8, Nakseongdae-dong, Kwanak-gu, Seoul 151-919, Korea. jclemens@ivi.int
New oral cholera vaccines offer safe and effective protection, providing both individual and community immunity. These cost-effective vaccines are practical for developing countries, aiding cholera control efforts.
Area of Science:
- Global Health
- Vaccinology
- Infectious Disease Epidemiology
Background:
- Cholera remains a significant global health threat, causing around 100,000 deaths annually, disproportionately affecting sub-Saharan Africa.
- Older parenteral cholera vaccines had limited efficacy, leading to their discontinuation as public health tools.
- Newer-generation oral cholera vaccines (OCVs) present improved safety and protection profiles.
Purpose of the Study:
- To evaluate the efficacy and public health impact of newer-generation oral cholera vaccines.
- To assess the cost-effectiveness and practicality of OCVs in developing countries.
- To position OCVs within the broader context of cholera prevention strategies.
Main Methods:
- Review of licensed killed and live oral cholera vaccines.
- Analysis of direct protection and herd immunity effects conferred by killed OCVs.
- Assessment of OCV administration requirements and cost-effectiveness.
Main Results:
- Killed oral cholera vaccines are currently manufactured and available, offering both direct and herd immunity.
- OCVs are highly cost-effective due to combined direct and herd immunity benefits.
- The ease of administration of OCVs by non-medical personnel enhances their practicality in resource-limited settings.
Conclusions:
- New-generation oral cholera vaccines are valuable public health tools for controlling endemic and epidemic cholera.
- OCVs are particularly attractive for developing countries due to their cost-effectiveness and ease of use.
- OCVs should be integrated with other preventive measures, such as improved water and sanitation, for comprehensive cholera control.
More Related Videos
Related Concept Videos
Cholera
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccine Production
Vaccines
Vaccinations
Microorganisms in Medicine and Therapeutics

